Abstract: Jet pump clamps fit to modified jet pump assemblies at the riser pipe-restrainer bracket junction. The clamp can secure the restrainer bracket and riser pipe, relieving any welds between the same stress in the same, while preventing the restrainer bracket from moving. The clamp may include multiple members on either side of the restrainer bracket that fit into surfaces of the riser pipe. When these members are drawn together through clamping action, the underlying riser pipe is compressed. Similarly, vertically-adjustable members may seat into and/or through the restrainer bracket to hold the bracket steady. Jet pump assemblies may be prepared by forming grooves in the riser pipe and hole(s) in the restrainer bracket(s) and spherical indentations about the same. Clamps may then be installed on the grooves and through the hole(s) at installation or during a maintenance outage in a commercial nuclear power plant.

Abstract: The invention features methods for detecting and quantifying the binding or inhibition of binding of species to biopolymers, e.g., nucleic acids. The invention is based on the use of probes that have magnetic relaxation properties that are affected by the presence of paramagnetic metal ions, e.g., Mn2+. Any class of biopolymer that binds metal ions at its active site or uses metal ion cofactors can be studied using these methods.

Abstract: A combination of Vitamin C and a quinone used as a supplemental treatment for an ovarian cancer patient. The combination may be administered before, during and after the patient undergoes a conventional cancer treatment protocol. The combination may be administered orally, intravenously, or intraperitoneally. Oral administration may be in the form of capsules containing a predetermined ratio of Vitamin C to Vitamin K3. The supplemental treatment is effective to inhibit metastases of cancer cells and inhibit tumor growth. The ratio of Vitamin C to Vitamin K3 is in the range of about 50 to 1 to about 250 to 1. A method for evaluating the effectiveness of the supplemental treatment includes monitoring the patient's serum DNase activity throughout the course of treatment.

Abstract: A combination of Vitamin C and a quinone used as a supplemental treatment for a cancer patient. The combination may be administered before, during and after the patient undergoes a conventional cancer treatment protocol. The combination may be administered orally, intravenously, or intraperitoneally. Oral administration may be in the form of capsules containing a predetermined ratio of Vitamin C to Vitamin K3. The supplemental treatment is effective to inhibit metastases of cancer cells and inhibit tumor growth. The ratio of Vitamin C to Vitamin K3 is in the range of about 50 to 1 to about 250 to 1. A method for evaluating the effectiveness of the supplemental treatment includes monitoring the patient's serum DNase activity throughout the course of treatment.

Abstract: The invention features methods for detecting and quantifying the binding or inhibition of binding of species to biopolymers, e.g., nucleic acids. The invention is based on the use of probes that have magnetic relaxation properties that are affected by the presence of paramagnetic metal ions, e.g., Mn2+. Any class of biopolymer that binds metal ions at its active site or uses metal ion cofactors can be studied using these methods.

Abstract: The invention features methods for detecting and quantifying the binding or inhibition of binding of species to biopolymers, e.g., nucleic acids. The invention is based on the use of probes that have magnetic relaxation properties that are affected by the presence of paramagnetic metal ions, e.g., Mn2+. Any class of biopolymer that binds metal ions at its active site or uses metal ion cofactors can be studied using these methods.